InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-21.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Hall Justin, Chief Executive Officer. Officer active across 1 company, notably NovaBay Pharmaceuticals, Inc.. Cumulatively, 2 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €28k. History available since 6 December 2021. The latest transaction was filed on 14 September 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hall Justin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,000 shares@ US$0.152.8% of flowCommon StockSEC:0001437749-22-022651:0
Canonical exit: 13 Dec 2022 (T+90)
69,767 shares@ US$0.4394.6% of flowCommon StockSEC:0001437749-21-027958:0
Canonical exit: 6 Mar 2022 (T+90)
2 of 2 declarations
About Hall Justin
Justin Hall is the CEO, General Counsel, and Director of NovaBay Pharmaceuticals, Inc. He oversees the company's operations and ensures legal compliance. His role is essential for the company's strategy and risk management.
